Investigating the performance of the sustainable cold supply chain in the pharmaceutical industry

dc.contributor.author Cansu Turan
dc.contributor.author Yucel Ozturkoglu
dc.date AUG 11
dc.date.accessioned 2025-10-06T16:19:54Z
dc.date.issued 2022
dc.description.abstract Purpose This study focuses on identifying potential challengers affecting cold chain performance in the pharmaceutical industry. Considering the history of humanity every pandemic experienced could only be controlled with the vaccine found. While the world is fighting the unforgettable epidemic called COVID-19 scientists are also working to find the therapeutic vaccine. The vaccines studied have different temperature storage and transport properties. In the pharmaceutical industry it is necessary to know and analyse every step of the cold supply chain to provide the most appropriate and safe cooling level. In addition it is important to understand the relationship between all the facilities equipment tools and materials needed to avoid mistakes along the chain. Design/methodology/approach Hence this study focuses on identifying potential challengers affecting sustainable cold supply chain performance in the pharmaceutical industry and proposing a conceptual framework that involves these main challengers. In this study firstly different main and sub-factors are defined from the literature and fuzzy Decision Making Trial and Evaluation Laboratory method is applied to analyse the causal link between these factors for an effective application. Findings Results showed that packaging transportation and shipping storage specifications and handling practices inventory management technical issues and delivery delay are the most affected factors during the sustainable cold supply chain performance in the pharmaceutical industry. This study offers both managerial implications and a roadmap that are designed with a holistic view to guide manufacturer logistics parties and even policymakers. Originality/value Some of the studies related to the pharmaceutical industry are monitoring and controlling the temperature in the cold supply chain steps, the other part is the studies where the chain steps are examined with a focus on production or transportation. While these issues are the focus the requirements and conditions of each stage of the supply chain must be studied for a safe effective and sustainable cold chain beyond the current global pandemic crisis. To the best of the authors' knowledge this is the first study that highlights identifying the potential challengers that affect cold supply chain performance for the pharmaceutical industry both theoretically and empirically solving the causal relationships among these challengers and designing a holistic framework.
dc.identifier.doi 10.1108/IJPHM-04-2021-0043
dc.identifier.issn 1750-6123
dc.identifier.uri http://dx.doi.org/10.1108/IJPHM-04-2021-0043
dc.identifier.uri https://gcris.yasar.edu.tr/handle/123456789/6073
dc.language.iso English
dc.publisher EMERALD GROUP PUBLISHING LTD
dc.relation.ispartof International Journal of Pharmaceutical and Healthcare Marketing
dc.source INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING
dc.subject Cold supply chain, Pharmaceutical industry, Fuzzy DEMATEL, Multi-criteria decision making
dc.subject INVENTORY MANAGEMENT, VACCINE, SYSTEM, MODEL
dc.title Investigating the performance of the sustainable cold supply chain in the pharmaceutical industry
dc.type Article
dspace.entity.type Publication
gdc.bip.impulseclass C4
gdc.bip.influenceclass C5
gdc.bip.popularityclass C4
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.endpage 467
gdc.description.startpage 448
gdc.description.volume 16
gdc.identifier.openalex W4295133198
gdc.index.type WoS
gdc.oaire.diamondjournal false
gdc.oaire.impulse 8.0
gdc.oaire.influence 2.7066187E-9
gdc.oaire.isgreen false
gdc.oaire.popularity 7.6116455E-9
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 03 medical and health sciences
gdc.oaire.sciencefields 0302 clinical medicine
gdc.oaire.sciencefields 0502 economics and business
gdc.oaire.sciencefields 05 social sciences
gdc.openalex.collaboration National
gdc.openalex.fwci 2.6041
gdc.openalex.normalizedpercentile 0.89
gdc.opencitations.count 13
gdc.plumx.crossrefcites 12
gdc.plumx.mendeley 98
gdc.plumx.scopuscites 16
oaire.citation.endPage 467
oaire.citation.startPage 448
publicationissue.issueNumber 3
publicationvolume.volumeNumber 16
relation.isOrgUnitOfPublication ac5ddece-c76d-476d-ab30-e4d3029dee37
relation.isOrgUnitOfPublication.latestForDiscovery ac5ddece-c76d-476d-ab30-e4d3029dee37

Files